ATLANTIC: another reason to investigate the disconnect between stent thrombosis and mortality? [PDF]
Aradi, Dániel, Sibbing, Dirk
core +1 more source
Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis. [PDF]
Yang Y +6 more
europepmc +1 more source
Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes. [PDF]
Li C +16 more
europepmc +1 more source
Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus [PDF]
Parker, W.A.E., Storey, R.F.
core +1 more source
Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trials. [PDF]
Navarese EP +12 more
europepmc +1 more source
Safety and efficacy of flow diversion for blood blister aneurysms: A comprehensive systematic review and meta-analysis. [PDF]
Maroufi SF +3 more
europepmc +1 more source
Effect of CYP3A4∗1G and CYP3A5∗3 Polymorphisms on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects [PDF]
Liyan Miao +5 more
core +1 more source
Risk of clopidogrel resistance in endovascular aneurysm stenting. [PDF]
Stanton M, Ng W, Jonathan A.
europepmc +1 more source
The performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome: the ASFREE prospective pilot study. [PDF]
Joo D, Jo S, Byoun JT, Cho JY, Yun KH.
europepmc +1 more source
Safety profile of ticagrelor: an analysis based on literature and database review. [PDF]
Liu R, Xiao L, Yan Q, Liu X.
europepmc +1 more source

